Given that GSK3β phosphorylates both normal and mutant HTT (Fig. 3), and previous MS-based findings identified a putative GSK3β phosphorylation site at Ser2657 (Table 1, [35]), we next tested the hypothesis that active GSK3β contributes to HD pathogenesis. Here, GSK3B is linked to Huntington disease.